{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:55:53Z","timestamp":1781556953830,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007137","name":"Northern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.atherosclerosis.2026.120776","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:21:35Z","timestamp":1778196095000},"page":"120776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Troms\u00f8 Study 2007-2021"],"prefix":"10.1016","volume":"417","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-1785","authenticated-orcid":false,"given":"Runa M.","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toralf","family":"Melsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja-Lisa","family":"L\u00f8chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wilsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellisiv B.","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl M.","family":"Brobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit D.","family":"Solbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120776_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCULATIONAHA.124.071079","article-title":"Albuminuria in cardiovascular, kidney, and metabolic disorders: a state-of-the-art review","volume":"151","author":"Claudel","year":"2025","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120776_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ekir.2018.01.015","article-title":"Mild albuminuria is a risk factor for faster GFR decline in the nondiabetic population","volume":"3","author":"Melsom","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120776_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ekir.2018.03.003","article-title":"Is very low always useful? The case of very low-grade albuminuria in kidney disease","volume":"3","author":"Cohen","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120776_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050752","article-title":"Update on diabetic kidney disease (DKD): focus on non-albuminuric DKD and cardiovascular risk","volume":"13","author":"Scilletta","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib5","article-title":"Comparison of nonalbuminuric and albuminuric diabetic kidney disease among patients with type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Shi","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120776_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.17925\/EE.2022.18.2.102","article-title":"Non-albuminuric diabetic kidney disease phenotype: beyond albuminuria","volume":"18","author":"D'Marco","year":"2022","journal-title":"touchREV Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104635","article-title":"Combining robust urine biomarkers to assess chronic kidney disease progression","volume":"93","author":"Bienaime","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120776_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/nep.13860","article-title":"Update on diagnosis, pathophysiology, and management of diabetic kidney disease","volume":"26","author":"Sugahara","year":"2021","journal-title":"Nephrology"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.991756","article-title":"New insights into proteinuria\/albuminuria","volume":"13","author":"Comper","year":"2022","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120776_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/HJH.0000000000000809","article-title":"Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals","volume":"34","author":"Tanaka","year":"2016","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120776_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7150\/ijms.25687","article-title":"Urinary orosomucoid A potential marker of inflammation in psoriasis","volume":"15","author":"Kustan","year":"2018","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.120","article-title":"Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis","volume":"48","author":"Park","year":"2016","journal-title":"Exp Mol Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120776_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107550","article-title":"Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure","volume":"9","author":"Hou","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120776_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/00365510802531100","article-title":"Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes","volume":"69","author":"Christiansen","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120776_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2014.05.921","article-title":"Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease","volume":"235","author":"Fandino-Vaquero","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/TCRM.S197633","article-title":"Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?","volume":"15","author":"Nemeth","year":"2019","journal-title":"Therapeut Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120776_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/14017431.2022.2079714","article-title":"Urinary orosomucoid is associated with diastolic dysfunction and carotid arteriopathy in the general population. Cross-sectional data from the tromso study","volume":"56","author":"Andreassen","year":"2022","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120776_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s125-002-8251-3","article-title":"Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with type II diabetes","volume":"45","author":"Christiansen","year":"2002","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120776_bib19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00125-004-1630-1","article-title":"Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up","volume":"48","author":"Christiansen","year":"2005","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120776_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jdiacomp.2013.05.008","article-title":"Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up","volume":"27","author":"Svendstrup","year":"2013","journal-title":"J Diabetes Complicat"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120776_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1076029616637185","article-title":"Serum and urinary orosomucoid in young patients with type 1 diabetes: a link between inflammation, microvascular complications, and subclinical atherosclerosis","volume":"22","author":"El-Beblawy","year":"2016","journal-title":"Clini Appl Thrombos\/Hemost : Off J Int Acad Clin Appl Thrombos\/Hemost"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120776_bib22","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/STROKEAHA.116.013374","article-title":"Orosomucoid, carotid plaque, and incidence of stroke","volume":"47","author":"Berntsson","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120776_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/08037051.2022.2128043","article-title":"Associations of urinary orosomucoid, N-acetyl-beta-D-glucosaminidase, and albumin with blood pressure and hypertension after 7 years","volume":"31","author":"Brobak","year":"2022","journal-title":"The Tromso Study Blood Press"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120776_bib24","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/ndt\/gfaf113","article-title":"Urinary orosomucoid and accelerated GFR decline: a 11-year follow-up study in a non-diabetic population","volume":"40","author":"Andreassen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib25","article-title":"Sex differences in risk factors for myocardial infarction: cohort study of UK biobank participants","volume":"363","author":"Millett","year":"2018","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120776_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9953","article-title":"Sex-specific risk factors associated with first acute myocardial infarction in young adults","volume":"5","author":"Lu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120776_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107624","article-title":"Sex and stroke risk factors: a review of differences and impact","volume":"33","author":"Hanna","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120776_bib28","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1681\/ASN.2022030323","article-title":"Sex differences in age-related loss of kidney function","volume":"33","author":"Melsom","year":"2022","journal-title":"J Am Soc Nephrol : JASN (J Am Soc Nephrol)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120776_bib29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Tromso study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2147\/CLEP.S265619","article-title":"Validity of acute cardiovascular outcome diagnoses recorded in European electronic health records: a systematic review","volume":"12","author":"Davidson","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/CLEP.S321293","article-title":"Validating acute myocardial infarction diagnoses in national health registers for use as endpoint in research: the tromso study","volume":"13","author":"Varmdal","year":"2021","journal-title":"Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120776_bib32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/14034948211021191","article-title":"Data from national health registers as endpoints for the Tromso study: correctness and completeness of stroke diagnoses","volume":"51","author":"Varmdal","year":"2023","journal-title":"Scand J Publ Health"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120776_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.atherosclerosis.2008.11.002","article-title":"Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events","volume":"204","author":"Solbu","year":"2009","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120776_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.11613\/BM.2016.044","article-title":"Urinary orosomucoid: validation of an automated immune turbidimetric test and its possible clinical use","volume":"26","author":"Kustan","year":"2016","journal-title":"Biochem Med"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120776_bib35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3109\/00365519009104951","article-title":"Preanalytical handling of stored urine samples, and measurement of beta 2-microglobulin, orosomucoid, albumin, transferrin and immunoglobulin G in urine by enzyme-linked immunosorbent assays (ELISA)","volume":"50","author":"Vittinghus","year":"1990","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120776_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/00016340701371322","article-title":"Pre-symptomatic increase in urine-orosomucoid excretion in pre-eclamptic women","volume":"86","author":"Kronborg","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120776_bib37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4S","key":"10.1016\/j.atherosclerosis.2026.120776_bib38","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120776_bib39","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120776_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003245","article-title":"Urine albumin\/creatinine ratio below 30 mg\/g is a predictor of incident hypertension and cardiovascular mortality","volume":"5","author":"Sung","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"9731","key":"10.1016\/j.atherosclerosis.2026.120776_bib40","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120776_bib42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120776_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41569-022-00797-4","article-title":"Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes","volume":"20","author":"Regitz-Zagrosek","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120776_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41512-018-0037-2","article-title":"Quantifying the added value of new biomarkers: how and how not","volume":"2","author":"Cook","year":"2018","journal-title":"Diagn Progn Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:25:56Z","timestamp":1781555156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0021915026001425"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120776","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Troms\u00f8 Study 2007-2021","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120776"}}